Cargando…

Annotation analysis for testing drug safety signals using unstructured clinical notes

BACKGROUND: The electronic surveillance for adverse drug events is largely based upon the analysis of coded data from reporting systems. Yet, the vast majority of electronic health data lies embedded within the free text of clinical notes and is not gathered into centralized repositories. With the i...

Descripción completa

Detalles Bibliográficos
Autores principales: LePendu, Paea, Iyer, Srinivasan V, Fairon, Cédrick, Shah, Nigam H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337270/
https://www.ncbi.nlm.nih.gov/pubmed/22541596
http://dx.doi.org/10.1186/2041-1480-3-S1-S5
Descripción
Sumario:BACKGROUND: The electronic surveillance for adverse drug events is largely based upon the analysis of coded data from reporting systems. Yet, the vast majority of electronic health data lies embedded within the free text of clinical notes and is not gathered into centralized repositories. With the increasing access to large volumes of electronic medical data—in particular the clinical notes—it may be possible to computationally encode and to test drug safety signals in an active manner. RESULTS: We describe the application of simple annotation tools on clinical text and the mining of the resulting annotations to compute the risk of getting a myocardial infarction for patients with rheumatoid arthritis that take Vioxx. Our analysis clearly reveals elevated risks for myocardial infarction in rheumatoid arthritis patients taking Vioxx (odds ratio 2.06) before 2005. CONCLUSIONS: Our results show that it is possible to apply annotation analysis methods for testing hypotheses about drug safety using electronic medical records.